𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon Therapy for Chronic Hepatitis B

✍ Scribed by Asselah, Tarik; Lada, Olivier; Moucari, Rami; Martinot, Michèle; Boyer, Nathalie; Marcellin, Patrick

Book ID
122503867
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
223 KB
Volume
11
Category
Article
ISSN
1089-3261

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autoantibodies during α-interferon thera
Autoantibodies during α-interferon therapy for chronic hepatitis B
✍ G. Fattovich; C. Betterle; L. Brollo; B. Pedini; G. Giustina; G. Realdi; A. Albe 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB

The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive

Does interferon therapy for chronic hepa
Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular carcinoma?
✍ Anna S. F. Lok 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Objective: To estimate the cost-effectiveness of interferon-a2B for the treatment of patients with chronic hepatitis B infection who are positive for hepatitis B e antigen (HBeAg). Design: Meta-analysis of nine randomized controlled trials and cost-effectiveness analysis, projecting the clinical an